ANALYSIS-US may compare medical products; companies wary - Forbes.com

ANALYSIS-US may compare medical products; companies wary - Forbes.com: "The idea of the federal government funding independent comparative effectiveness studies has drug and medical device makers jittery. They fear such information would influence insurance coverage and jeopardize billions of dollars worth of sales for their newest and most lucrative treatments."